General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug pricing proposals. Medicare rebate reform, the 340B program, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). PASTEUR Act. Pharmacy benefit manager reform proposals.
Source-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- WILLIAMS AND JENSEN, PLLC
- Client
- PFIZER
- Filing UUID
- 8f8291ab-2076-4aa4-90c9-f8c2367e7eb5
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Tax issues affecting the pharmaceutical industry including international tax. Vaccine excise tax issues and VICP.
Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals.
Issues related to pharmaceutical manufacturing and development, trade and tariffs. Legislative proposals related to WTO TRIPS Waiver.
Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Support for immunization access.
Issues related to pharmaceutical manufacturing and development.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.